Published in Diabetes Metab on November 01, 2006
Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med (2007) 2.08
Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol (2008) 1.97
Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition (2010) 1.89
Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study. Diabetes Care (2011) 1.66
Epidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis. J Alzheimers Dis (2009) 1.62
ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J Neurochem (2011) 1.52
Insulin resistance and Alzheimer's disease. BMB Rep (2009) 1.49
Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res (2012) 1.48
Role of vascular risk factors and vascular dysfunction in Alzheimer's disease. Mt Sinai J Med (2010) 1.28
Type 2 diabetes and cognitive decline in middle-aged men and women: the Doetinchem Cohort Study. Diabetes Care (2010) 1.25
Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis. Curr Opin Investig Drugs (2009) 1.21
Brain metabolic dysfunction at the core of Alzheimer's disease. Biochem Pharmacol (2013) 1.21
Impact of energy intake and expenditure on neuronal plasticity. Neuromolecular Med (2008) 1.17
Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease. J Alzheimers Dis (2009) 1.15
Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis. J Alzheimers Dis (2009) 1.07
Interactive effects of apolipoprotein E type 4 genotype and cerebrovascular risk on neuropsychological performance and structural brain changes. J Stroke Cerebrovasc Dis (2010) 1.02
Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview. J Pharmacovigil (2014) 0.97
Genetic study between SIRT1, PPARD, PGC-1alpha genes and Alzheimer's disease. J Neurol (2008) 0.95
Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment. Mol Neurodegener (2009) 0.95
Direct quantitation of psychosine from alkaline-treated lipid extracts with a semi-synthetic internal standard. J Lipid Res (2008) 0.93
Brain deletion of insulin receptor substrate 2 disrupts hippocampal synaptic plasticity and metaplasticity. PLoS One (2012) 0.92
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease. Front Biosci (Elite Ed) (2012) 0.92
Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed. J Alzheimers Dis (2012) 0.91
Ceramide-mediated insulin resistance and impairment of cognitive-motor functions. J Alzheimers Dis (2010) 0.91
Activation of AMP-activated protein kinase alleviates high-glucose-induced dysfunction of brain microvascular endothelial cell tight-junction dynamics. Free Radic Biol Med (2012) 0.91
White matter hyperintensity and cognitive functioning in the racial and ethnic minority cohort of the Framingham Heart Study. Neuroepidemiology (2010) 0.90
Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration. BMC Endocr Disord (2010) 0.89
Mechanisms of ceramide-mediated neurodegeneration. J Alzheimers Dis (2009) 0.88
Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors. Front Aging Neurosci (2013) 0.87
Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease - How Anti-Diabetics Could be a Solution for Dementia. Front Endocrinol (Lausanne) (2014) 0.87
Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease. Curr Neuropharmacol (2011) 0.85
The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging. Psychiatry Res (2014) 0.83
Brain alterations and clinical symptoms of dementia in diabetes: aβ/tau-dependent and independent mechanisms. Front Endocrinol (Lausanne) (2014) 0.83
Cardiomyocyte contractile dysfunction in the APPswe/PS1dE9 mouse model of Alzheimer's disease. PLoS One (2009) 0.82
Morphometry of the hippocampal microvasculature in post-stroke and age-related dementias. Neuropathol Appl Neurobiol (2014) 0.81
The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats. J Neural Transm (Vienna) (2011) 0.81
Cerebral small vessel disease and Alzheimer's disease. Clin Interv Aging (2015) 0.80
Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal. World J Diabetes (2015) 0.80
Cognition and Hemodynamics. Curr Cardiovasc Risk Rep (2012) 0.79
Steviol glycosides modulate glucose transport in different cell types. Oxid Med Cell Longev (2013) 0.78
Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System. Front Endocrinol (Lausanne) (2014) 0.78
Exercise and cognitive function: a hypothesis for the association of type II diabetes mellitus and Alzheimer's disease from an evolutionary perspective. Diabetol Metab Syndr (2009) 0.78
Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases. Panminerva Med (2012) 0.77
[Diabetes and dementia]. Z Gerontol Geriatr (2012) 0.77
Inhibitory activities of selected Kampo formulations on human aldose reductase. BMC Complement Altern Med (2014) 0.77
Chronic type 2 diabetes reduces the integrity of the blood-brain barrier by reducing tight junction proteins in the hippocampus. J Vet Med Sci (2016) 0.77
Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons. PLoS One (2016) 0.76
Effect of pregabalin on contextual memory deficits and inflammatory state-related protein expression in streptozotocin-induced diabetic mice. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.76
Diabetes alters aromatase enzyme levels in sciatic nerve and hippocampus tissues of rats. Cell Mol Neurobiol (2009) 0.76
Retracted Resveratrol attenuates lipopolysaccharide-induced dysfunction of blood-brain barrier in endothelial cells via AMPK activation. Korean J Physiol Pharmacol (2016) 0.76
Inositol-Requiring Enzyme 1-Dependent Activation of AMPK Promotes Brucella abortus Intracellular Growth. J Bacteriol (2016) 0.75
High glucose upregulates BACE1-mediated Aβ production through ROS-dependent HIF-1α and LXRα/ABCA1-regulated lipid raft reorganization in SK-N-MC cells. Sci Rep (2016) 0.75
Using Multistate Observational Studies to Determine Role of Hypertension and Diabetes as Risk Factors for Dementia. J Neurosci Rural Pract (2016) 0.75
Heat shock response and insulin-associated neurodegeneration. Trends Pharmacol Sci (2011) 0.75
Blood Brain Barrier Injury in Diabetes: Unrecognized Effects on Brain and Cognition. J Neuroimmune Pharmacol (2017) 0.75
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group. Lancet (1995) 4.50
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry (1992) 4.16
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet (2001) 3.69
A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci (1993) 3.16
Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab (2003) 3.10
Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke Group. N Engl J Med (1996) 2.55
Prevalence and severity of microbleeds in a memory clinic setting. Neurology (2006) 2.29
Thrombolysis in cervical artery dissection--data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database. Eur J Neurol (2012) 2.07
Comparison of 7.0-T T₂*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates. Cerebrovasc Dis (2011) 2.05
Early predictors of death and disability after acute cerebral ischemic event. Stroke (1995) 2.04
Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome. J Neurol Neurosurg Psychiatry (2004) 1.95
Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology (1995) 1.86
Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity. Neurology (2006) 1.77
Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia (2004) 1.75
Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol (1995) 1.67
Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology (2011) 1.65
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology. Tuberculosis (Edinb) (2003) 1.55
Contrast-enhanced three-dimensional fast imaging with steady-state precession (FISP) MR angiography of supraaortic vessels: preliminary results. AJNR Am J Neuroradiol (1998) 1.48
Helical CT for the follow-up of cervical internal carotid artery dissections. AJNR Am J Neuroradiol (1998) 1.43
Decreased morbidity from acute bacterial spinal epidural abscesses using computed tomography and nonsurgical treatment in selected patients. Ann Neurol (1985) 1.43
[Fifteen practical questions concerning gestational diabetes]. Gynecol Obstet Fertil (2007) 1.41
The anatomy of aphasia revisited. Neurology (2000) 1.41
Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology (2001) 1.40
Plasma lipid response and nutritional adequacy in hypercholesterolemic subjects on the American Heart Association Step-One Diet. Arch Fam Med (1993) 1.40
[Recommendations for the use of intravenous thrombolytic therapy in cerebrovascular ischemic accident. French Society of Neurovascular Disorders]. Rev Neurol (Paris) (2000) 1.39
Minimal endoscopic approach to subperiosteal orbital abscess. Arch Otolaryngol Head Neck Surg (1997) 1.39
Dystonia after striatopallidal and thalamic stroke: clinicoradiological correlations and pathophysiological mechanisms. J Neurol Neurosurg Psychiatry (1998) 1.37
Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging. Eur Neurol (1997) 1.36
Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol (1996) 1.35
White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol (1998) 1.25
Etiology of first-ever ischaemic stroke in European young adults: the 15 cities young stroke study. Eur J Neurol (2013) 1.25
Is mild gestational hyperglycaemia associated with maternal and neonatal complications? The Diagest Study. Diabet Med (2000) 1.23
Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST). J Neurol Neurosurg Psychiatry (2005) 1.21
Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases. Brain (2001) 1.17
Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand? SAFE I Study Investigators. Heart (1999) 1.16
Differential features of carotid and vertebral artery dissections: the CADISP study. Neurology (2011) 1.13
Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance. J Cereb Blood Flow Metab (2000) 1.13
Pneumoperitoneum. Br Med J (1944) 1.10
Anxiety and depression associated with caffeinism among psychiatric inpatients. Am J Psychiatry (1978) 1.08
Role of white matter lesions in cognitive impairment of vascular origin. Alzheimer Dis Assoc Disord (2000) 1.08
Confusional state in stroke: relation to preexisting dementia, patient characteristics, and outcome. Stroke (1999) 1.07
The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes. J Immunol (1999) 1.04
Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke (1997) 1.03
Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery (1986) 1.03
Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzyme. Biochem Soc Trans (2005) 1.03
Increasing incidence of abnormal glucose tolerance in women with prior abnormal glucose tolerance during pregnancy: DIAGEST 2 study. Diabet Med (2007) 1.03
The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study. Eur J Neurol (2011) 1.03
Helical CT for the diagnosis of extracranial internal carotid artery dissection. Stroke (1996) 1.02
The effects of social support on women's health during pregnancy, labor and delivery, and the postpartum period. Fam Med (1991) 1.00
Preliminary experience using contrast-enhanced MR angiography to assess vertebral artery structure for the follow-up of suspected dissection. AJNR Am J Neuroradiol (1999) 1.00
Gender and cervical artery dissection. Eur J Neurol (2011) 1.00
IV thrombolysis and statins. Neurology (2011) 0.99
Medial temporal lobe atrophy in stroke patients: relation to pre-existing dementia. J Neurol Neurosurg Psychiatry (1998) 0.99
Antithrombin, protein C and protein S levels in 127 consecutive young adults with ischemic stroke. Acta Neurol Scand (1998) 0.99
Stroke units from scientific evidence to practice: the experience of the Lille stroke unit. Cerebrovasc Dis (2000) 0.99
Long-term metabolic outcome and quality of life after laparoscopic adjustable gastric banding in obese patients with type 2 diabetes mellitus or impaired fasting glucose. Br J Surg (2010) 0.98
Identification of a small tetraheme cytochrome c and a flavocytochrome c as two of the principal soluble cytochromes c in Shewanella oneidensis strain MR1. Appl Environ Microbiol (2001) 0.97
Depressive symptoms after stroke and relationship with dementia: A three-year follow-up study. Neurology (2004) 0.96
Visual rating of hippocampal atrophy: correlation with volumetry. J Neurol Neurosurg Psychiatry (1994) 0.95
Neurinomas of the trigeminal nerve. Acta Neurochir (Wien) (1986) 0.94
Kinetic and crystallographic analysis of the key active site acid/base arginine in a soluble fumarate reductase. Biochemistry (2001) 0.94
[Myasthenia gravis and pregnancy: clinical course and management of delivery and the postpartum phase]. Rev Neurol (Paris) (2006) 0.94
[Giant arteriovenous malformation of the vein of Galen in a 50 year old man]. Rev Neurol (Paris) (2002) 0.93
Biochemical and immunogenetic analysis of an immunodominant peptide (B6dom1) encoded by the classical H7 minor histocompatibility locus. J Immunol (1999) 0.93
Why are stroke patients prone to develop dementia? J Neurol (1997) 0.92
Management of subdural intracranial empyemas should not always require surgery. J Neurol Neurosurg Psychiatry (1986) 0.92
Leukoaraiosis more than dementia is a predictor of stroke recurrence. Stroke (2003) 0.92
Higher carbohydrate intake is associated with decreased incidence of newborn macrosomia in women with gestational diabetes. J Am Diet Assoc (2001) 0.92
Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis. Biochem Soc Trans (2003) 0.92
Blood ketone monitoring: a comparison between gestational diabetes and non-diabetic pregnant women. Diabetes Metab (2006) 0.92
Liver transplantation eliminates insulin needs of a diabetic patient. Diabetes Metab (2000) 0.92
Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients. J Neurol (2003) 0.92
[Cervical necrotizing fasciitis disclosing HIV infection]. Ann Otolaryngol Chir Cervicofac (1997) 0.91
Thalamic tremor: correlations with three-dimensional magnetic resonance imaging data and pathophysiological mechanisms. Mov Disord (2000) 0.90
Autosomal dominant migraine with MRI white-matter abnormalities mapping to the CADASIL locus. Neurology (1995) 0.90
The relationship of oocyte diameter and incubation temperature to incubation time in temperate freshwater fish species. J Fish Biol (2009) 0.90
Prevalence of diagnosed type 2 diabetes mellitus in the French general population: the INSTANT study. Diabetes Metab (2008) 0.90
Influence of cognitive impairment on the institutionalisation rate 3 years after a stroke. J Neurol Neurosurg Psychiatry (2006) 0.90
Treating diabetes with islet transplantation: lessons from the past decade in Lille. Diabetes Metab (2014) 0.89
Thymic and extrathymic differentiation and expansion of T lymphocytes following bone marrow transplantation in irradiated recipients. Exp Hematol (1997) 0.88
Poststroke dementia. Cerebrovasc Dis (2006) 0.88
Pregnancy induced hypertension in women with gestational carbohydrate intolerance: the diagest study. Eur J Obstet Gynecol Reprod Biol (2002) 0.88
Migraine in cervical artery dissection and ischemic stroke patients. Neurology (2012) 0.87
Relationship between leuko-araiosis and blood pressure variability in the elderly. Eur Neurol (2001) 0.87
Parkinson's disease and basal ganglia calcifications: prevalence and clinico-radiological correlations. Clin Neurol Neurosurg (1992) 0.87
Splice site mutation causing a seven amino acid Notch3 in-frame deletion in CADASIL. Neurology (2000) 0.87
No loss of genomic imprinting of IGF-II and H19 in placentas of diabetic pregnancies with fetal macrosomia. Growth Horm IGF Res (2007) 0.87
Silent infarcts in patients with ischemic stroke are related to age and size of the left atrium. Stroke (1993) 0.87
Evidence for atrophy of the corpus callosum in Alzheimer's disease. Eur Neurol (1994) 0.87
Early hypopituitarism following cavernous sinus thrombosis: total recovery within 1 year. Clin Neurol Neurosurg (1991) 0.86
Internal carotid arterial stenosis: CT angiography with volume rendering. Radiology (1999) 0.86
On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens. Eur J Immunol (1997) 0.86
One-and-a-half syndrome in pontine infarcts: MRI correlates. Neuroradiology (1999) 0.86
Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases: a semi-quantitative 7.0 T magnetic resonance imaging study. Eur J Neurol (2014) 0.85
Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age. Thromb Res (2001) 0.85
Cerebral venous infarction following thrombosis of the draining vein of a venous angioma (developmental abnormality). Cerebrovasc Dis (2000) 0.85